Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vaccines
Pharma
GSK, Pfizer end RSV patent feud amid vaccine market uncertainty
The settlement comes after a U.K. court in November sided with Pfizer, ruling that two GSK RSV vaccine patents were invalid.
Angus Liu
Apr 4, 2025 10:55am
Clover rejects Gavi demand for $224M repayment on COVID deal
Mar 24, 2025 11:36am
Valneva nabs $33M US supply pact for Japanese encephalitis shot
Feb 3, 2025 11:32am
Survey shows widespread support for access to vaccines
Jan 29, 2025 11:30am
Moderna CEO confronts challenges for RSV, COVID businesses
Jan 7, 2025 11:00am
2024 approvals: Biopharma delivered 55 new drugs, biologics
Jan 2, 2025 3:00am
816b.jpg?VersionId=r72tTedUCU7e8jFmoH.kb_bE4jzZ91ct)
